IVGN Invitrogen (MM)

Invitrogen Corporation (Nasdaq: IVGN) announced it will present at the UBS Global Life Sciences Conference on Tuesday, September 23rd, at 11:30 a.m. Eastern Time at the Grand Hyatt Hotel in New York City. To hear a live webcast of the presentation, visit the investor relations page on the Company's web site at www.invitrogen.com. A replay of the webcast will be available for approximately 30 days after the conference. About Invitrogen Corporation Invitrogen Corporation (NASDAQ:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of approximately $1.3 billion in 2007. For more information, visit www.invitrogen.com.